ArticleThe Journal of biological chemistry2012

Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease.

Fredrik Jeppsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.